EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Lanthanum carbonate treatment of hyperphosphatemia in end-stage renal disease


Journal of Pharmacy Technology 22(2): 99-104
Lanthanum carbonate treatment of hyperphosphatemia in end-stage renal disease
Objective: To review the literature on the safety and efficacy of lanthanum carbonate for the treatment of hyperphosphatemia in patients with end-stage renal disease (ESRD).Data Sources: Primary literature was obtained through a PubMed search (1966-September 2005) using the key terms Fosrenol and lanthanum carbonate.

(PDF same-day service: $19.90)

Accession: 012255440

DOI: 10.1177/875512250602200206



Related references

Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis--system review of lanthanum carbonate. Renal Failure 35(10): 1455-1464, 2014

The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease. Value in Health 10(1): 32-41, 2007

Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. Value in Health 14(8): 1002-1009, 2012

Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate. International Journal of Nephrology and Renovascular Disease 2: 1-8, 2009

Safety and efficacy evaluation of lanthanum carbonate for hyperphosphatemia in end-stage renal disease patients. Contributions to Nephrology 185: 42-55, 2016

Efficacy and safety of lanthanum carbonate in the treatment of hyperphosphatemia in Chinese chronic renal failure patients. Journal of the American Society of Nephrology 14(Abstracts Issue): 204A, November, 2003

Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in chronic kidney disease before and during dialysis. Value in Health 14(6): 852-858, 2011

Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease. Indian Journal of Pharmacology 41(4): 187-191, 2010

Lanthanum carbonate (Fosrenol) efficacy and tolerability in the treatment of hyperphosphatemic patients with end-stage renal disease. Clinical Nephrology 63(6): 461-470, 2005

The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease. Clinical Nephrology 64(6): 428-437, 2005